Ina-Respond

Academic / Other · 9 registered clinical trials.

Status	Trial	Phase	Started
Completed	Observational Research on Infectious Disease Outbreaks and Difficult Cases of Unidentified Etiology in Indones Infectious Disease	—	2020-11-18
Completed	Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients Covid19, Corona Virus Infection, SAR	Phase 1	2020-11-14
Completed	Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia Infectious Disease, SARS-CoV Infection, Covid19	Phase 3	2020-10-15
Completed	Validation of POC-CCA Rapid Urine Test for Qualitative Detection of Schistosoma Japonicum Aged ≥2 Years in Schistosomiasis Affected Areas	—	2019-09-04
Completed	Integration of Mental Health in HIV Clinic to Increase the Success of ARV Treatment in PLWHA in Hospitals HIV/AIDS, Depression	—	2019-07-22
Completed	HIV Infection and Risk Related Coinfections/Comorbidities in Indonesia HIV	—	2018-01-09
Completed	Evaluation of GeneXpert HIV-1 as The Gold Standard Test for HIV-1 Viral Load Count HIV	—	2018-01-08
Completed	Tuberculosis Research of INA-RESPOND On Drug Resistance Lung Tuberculosis, MDR TB	—	2017-02-13
Completed	The Etiology of Acute Febrile Illness Requiring Hospitalization Acute Febrile Illness	—	2013-07-01